Law360, New York (February 16, 2010, 5:28 PM ET) -- Arkansas has struck an $18.5 million settlement in its suit against Eli Lilly & Co. over the alleged off-label promotion of schizophrenia drug Zyprexa, the state's attorney general announced Tuesday.
The two sides entered into a consent judgment in the Circuit Court of Pulaski County, without Eli Lilly admitting to any wrongdoing.
“When drug companies seek to circumvent FDA measures meant to ensure the safety of our citizens, it endangers lives and unnecessarily increases costs,” Attorney General Dustin McDaniel said. “This lawsuit and settlement should send...
Lilly Settles Ark.'s Zyprexa Marketing Suit For $18.5M
To view the full article, take a free trial now.
